The US Food and Drug Administration (FDA) is caught between a rock and a hard place. And CIRM is going to try and help them get out from under that. As things stand today, if the FDA approves a therapy quickly and a patient later dies from it, then they are widely criticized. If they … Continue reading Doing nothing is not OK: A call for change at the FDA
Randy Mills
Giving Thanks by Looking Forward
The CIRM Team gather to give Thanks Thanksgiving is traditionally a time of reflection, a time to look back and express gratitude for all the good things that have happened in the past year. At CIRM we have a lot to be thankful for but this Thanksgiving we are looking forward, not backward. We’re unveiling … Continue reading Giving Thanks by Looking Forward
Improving process drives progress in stem cell research
Process is not a sexy word. No one gets excited thinking about improving a process. Yet behind every great idea, behind every truly effective program is someone who figured out a way to improve the process, to make that idea not just work, but work better. It’s not glamorous. Sometimes it’s not even pretty. But … Continue reading Improving process drives progress in stem cell research
Pushing, pulling and dragging stem cell research forward
Government agencies are known for many things, but generally speaking a willingness to do some voluntary, deep self-examination is not one of them. However, for the last few weeks CIRM has been doing a lot of introspection as we develop a new Strategic Plan, a kind of road map for where we are heading. But … Continue reading Pushing, pulling and dragging stem cell research forward
Partnering with Big Pharma to benefit patients
Our mission at CIRM is to accelerate the development of stem cell therapies for patients with unmet medical needs. One way we have been doing that is funding promising research to help it get through what’s called the “Valley of Death.” This is the time between a product or project showing promise and the time … Continue reading Partnering with Big Pharma to benefit patients
Faster, better, more efficient. Challenging? That too. An update on CIRM 2.0.
Changing direction is never easy. The greater the change the greater the likelihood you’ll have to make adjustments and do some fine-tuning along the way to make sure you get it right. On January 1st of this year we made a big change, launching CIRM 2.0. Our President and CEO Dr. C. Randal Mills called … Continue reading Faster, better, more efficient. Challenging? That too. An update on CIRM 2.0.
CIRM 2.0: A New Year, a new start, a new way to advance research
It’s tradition to begin the New Year by making a resolution. Wikipedia has a wonderful description of what this involves saying it is where “a person makes a promise to do an act of self-improvement or something slightly nice, such as opening doors for people beginning from New Year’s Day.” Well, by that criteria, CIRM … Continue reading CIRM 2.0: A New Year, a new start, a new way to advance research
New Stem Cell Agency President Says; “It’s all about the Patients”
This week we held two events to introduce our new President, C. Randal Mills, to our biggest supporters, the researchers we fund and the patient advocates who are looking to stem cell science for treatments and cures. The events were at our offices in San Francisco and at the University of Southern California campus in … Continue reading New Stem Cell Agency President Says; “It’s all about the Patients”
New Stem Cell Agency President Says; “It’s all about the Patients”
This week we held two events to introduce our new President, C. Randal Mills, to our biggest supporters, the researchers we fund and the patient advocates who are looking to stem cell science for treatments and cures. The events were at our offices in San Francisco and at the University of Southern California campus in … Continue reading New Stem Cell Agency President Says; “It’s all about the Patients”
The Stem Cellar 